Yüklüyor......
Preventing clinically important deterioration with single-inhaler triple therapy in COPD
Clinically important deterioration (CID) is a novel composite end-point (lung function, health status, exacerbations) for assessing disease stability in patients with chronic obstructive pulmonary disease (COPD). We prospectively analysed CID in the FULFIL study. FULFIL (ClinicalTrials.gov NCT023451...
Kaydedildi:
| Yayımlandı: | ERJ Open Res |
|---|---|
| Asıl Yazarlar: | , , , , , , , , |
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
European Respiratory Society
2018
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6168763/ https://ncbi.nlm.nih.gov/pubmed/30302335 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1183/23120541.00047-2018 |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|